In-vitro activity of LY146032 against Staphylococcus aureus and S. epidermidis.
about
Influence of daptomycin on staphylococcal abscesses and experimental tobramycin nephrotoxicityIn vivo pharmacodynamic activity of daptomycinIn vitro activities of a new lipopeptide, HMR 1043, against susceptible and resistant gram-positive isolatesImpact of high-inoculum Staphylococcus aureus on the activities of nafcillin, vancomycin, linezolid, and daptomycin, alone and in combination with gentamicin, in an in vitro pharmacodynamic model.
P2860
In-vitro activity of LY146032 against Staphylococcus aureus and S. epidermidis.
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年学术文章
@wuu
1987年学术文章
@zh
1987年学术文章
@zh-cn
1987年学术文章
@zh-hans
1987年学术文章
@zh-my
1987年学术文章
@zh-sg
1987年學術文章
@yue
1987年學術文章
@zh-hant
name
In-vitro activity of LY146032 against Staphylococcus aureus and S. epidermidis.
@en
In-vitro activity of LY146032 against Staphylococcus aureus and S. epidermidis.
@nl
type
label
In-vitro activity of LY146032 against Staphylococcus aureus and S. epidermidis.
@en
In-vitro activity of LY146032 against Staphylococcus aureus and S. epidermidis.
@nl
prefLabel
In-vitro activity of LY146032 against Staphylococcus aureus and S. epidermidis.
@en
In-vitro activity of LY146032 against Staphylococcus aureus and S. epidermidis.
@nl
P2093
P356
P1476
In-vitro activity of LY146032 against Staphylococcus aureus and S. epidermidis.
@en
P2093
Coudron PE
Johnston JL
P304
P356
10.1093/JAC/20.4.505
P407
P577
1987-10-01T00:00:00Z